Details of the Drug

General Information of Drug (ID: DMFCPG0)

Drug Name
CAR-T cells targeting GD2
Indication
Disease Entry ICD 11 Status REF
Glioma 2A00.0 Phase 1/2 [1]
Lung cancer 2C25.0 Phase 1/2 [2]
Glioblastoma multiforme 2A00.0 Phase 1 [3]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D0E1ST
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ganglioside GD2 (GD2) TT80ARU NOUNIPROTAC CAR-T-Cell-Therapy [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03252171) CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
2 ClinicalTrials.gov (NCT03356808) Antigen-specific T Cells Against Lung Cancer
3 ClinicalTrials.gov (NCT03170141) Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme